Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Sarah Milgrom

Concepts (347)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
34
2024
134
9.550
 Why?
Radiotherapy, Intensity-Modulated
15
2024
129
3.270
 Why?
Positron Emission Tomography Computed Tomography
14
2023
85
2.950
 Why?
Tumor Burden
6
2024
286
2.300
 Why?
Fluorodeoxyglucose F18
7
2023
129
2.300
 Why?
Antineoplastic Combined Chemotherapy Protocols
30
2024
1565
2.180
 Why?
Lymphoma
9
2024
196
2.100
 Why?
Radiotherapy
12
2020
188
1.930
 Why?
Central Nervous System Neoplasms
9
2021
149
1.860
 Why?
Radiation Injuries
8
2021
135
1.840
 Why?
Radiopharmaceuticals
6
2023
168
1.750
 Why?
Radiotherapy Planning, Computer-Assisted
12
2024
124
1.700
 Why?
Lymphoma, Non-Hodgkin
6
2024
77
1.610
 Why?
Neoplasm Staging
30
2021
1295
1.500
 Why?
Lymphoma, Large B-Cell, Diffuse
8
2024
112
1.470
 Why?
Radiotherapy Dosage
16
2024
252
1.350
 Why?
Neoplasm Recurrence, Local
13
2023
964
1.350
 Why?
Sarcoma
2
2023
176
1.320
 Why?
Salvage Therapy
11
2024
134
1.280
 Why?
Endometrial Neoplasms
4
2014
164
1.200
 Why?
Mediastinal Neoplasms
5
2021
38
1.190
 Why?
Hematopoietic Stem Cell Transplantation
7
2024
573
1.150
 Why?
Combined Modality Therapy
22
2024
1206
1.110
 Why?
Whole-Body Irradiation
2
2024
76
1.060
 Why?
Radiotherapy, Adjuvant
7
2024
210
1.050
 Why?
Prognosis
22
2023
3794
1.000
 Why?
Rhabdomyosarcoma
2
2024
64
0.990
 Why?
Positron-Emission Tomography
8
2024
288
0.970
 Why?
Neoplasms
4
2024
2470
0.960
 Why?
Sarcoma, Ewing
2
2024
89
0.950
 Why?
Disease Progression
7
2024
2635
0.920
 Why?
Humans
109
2025
129622
0.890
 Why?
Radiation
2
2020
24
0.850
 Why?
Craniopharyngioma
1
2024
82
0.850
 Why?
Radiation Exposure
1
2023
45
0.840
 Why?
Hematologic Neoplasms
1
2025
140
0.820
 Why?
Pituitary Neoplasms
1
2024
184
0.810
 Why?
Adenocarcinoma
3
2014
898
0.800
 Why?
Lymphoma, Follicular
5
2020
38
0.790
 Why?
Salivary Glands
2
2021
29
0.770
 Why?
Smiling
1
2021
6
0.760
 Why?
Retrospective Studies
38
2024
14519
0.760
 Why?
Xerostomia
1
2021
17
0.740
 Why?
Tooth Abnormalities
1
2021
13
0.730
 Why?
Brachytherapy
1
2021
104
0.710
 Why?
Young Adult
32
2025
12426
0.680
 Why?
Chemoradiotherapy
9
2021
210
0.680
 Why?
Proton Therapy
1
2020
12
0.680
 Why?
Face
1
2021
165
0.670
 Why?
Child
21
2025
20882
0.670
 Why?
Aged
41
2020
22099
0.650
 Why?
Doxorubicin
12
2020
325
0.650
 Why?
Intraocular Lymphoma
2
2016
3
0.650
 Why?
Aged, 80 and over
21
2020
7084
0.650
 Why?
Middle Aged
49
2024
31150
0.640
 Why?
Bleomycin
8
2020
244
0.620
 Why?
Rectal Neoplasms
3
2016
136
0.620
 Why?
Lymphoma, B-Cell, Marginal Zone
4
2019
12
0.610
 Why?
Adult
51
2024
35572
0.600
 Why?
Vinblastine
8
2020
69
0.590
 Why?
Cerebellar Neoplasms
1
2020
156
0.590
 Why?
Dacarbazine
8
2020
94
0.580
 Why?
Medulloblastoma
1
2020
198
0.580
 Why?
Recurrence
9
2020
1007
0.550
 Why?
Meningeal Neoplasms
1
2018
93
0.530
 Why?
Leukemia, Myeloid, Acute
2
2023
592
0.530
 Why?
Leukemia, Biphenotypic, Acute
1
2016
3
0.530
 Why?
Cancer Survivors
1
2021
263
0.520
 Why?
Adolescent
26
2025
20391
0.520
 Why?
Patient Satisfaction
1
2020
633
0.510
 Why?
Head and Neck Neoplasms
1
2021
544
0.510
 Why?
Female
56
2024
68770
0.500
 Why?
Breast Neoplasms
5
2019
2142
0.490
 Why?
Treatment Outcome
25
2024
10226
0.490
 Why?
Graft vs Host Disease
2
2024
241
0.490
 Why?
Brain Neoplasms
3
2023
1171
0.490
 Why?
Eye Diseases
1
2016
81
0.480
 Why?
Survival Rate
12
2021
1877
0.460
 Why?
Male
50
2024
63674
0.450
 Why?
Disease-Free Survival
12
2020
648
0.440
 Why?
Consensus
4
2024
615
0.440
 Why?
Follow-Up Studies
15
2020
4896
0.440
 Why?
Glycolysis
3
2023
311
0.430
 Why?
Endometrium
1
2013
61
0.420
 Why?
Peritoneal Cavity
1
2013
31
0.420
 Why?
Stomach Neoplasms
3
2019
99
0.420
 Why?
Digestive System Surgical Procedures
1
2014
96
0.420
 Why?
Lymphoma, B-Cell
3
2021
105
0.410
 Why?
Palate, Hard
1
2012
5
0.410
 Why?
Infertility, Female
1
2013
104
0.400
 Why?
Chemoradiotherapy, Adjuvant
3
2019
42
0.400
 Why?
Image Enhancement
1
2013
167
0.400
 Why?
Mastectomy, Simple
1
2012
1
0.400
 Why?
Neoadjuvant Therapy
2
2016
383
0.390
 Why?
Carcinoma, Lobular
1
2012
48
0.380
 Why?
Sentinel Lymph Node Biopsy
1
2012
107
0.370
 Why?
Carcinoma, Ductal, Breast
1
2012
82
0.370
 Why?
Adrenal Gland Neoplasms
1
2012
84
0.360
 Why?
Organs at Risk
3
2020
31
0.360
 Why?
Disease Management
6
2019
589
0.330
 Why?
Tomography, X-Ray Computed
7
2023
2535
0.330
 Why?
Biopsy
6
2020
1097
0.330
 Why?
Radiotherapy, Image-Guided
3
2019
34
0.330
 Why?
Cellulitis
1
2009
48
0.320
 Why?
Carcinoma, Squamous Cell
1
2014
626
0.310
 Why?
Kaplan-Meier Estimate
7
2020
857
0.310
 Why?
Lymphocytes
3
2020
377
0.300
 Why?
Lymphoma, Mantle-Cell
2
2019
19
0.300
 Why?
Multiple Myeloma
2
2020
125
0.290
 Why?
Survival Analysis
6
2020
1274
0.270
 Why?
Cardiotoxicity
2
2023
33
0.260
 Why?
Pregnancy Complications, Neoplastic
2
2017
53
0.260
 Why?
Patient Selection
2
2022
663
0.260
 Why?
Testicular Neoplasms
2
2018
104
0.250
 Why?
Radiation Pneumonitis
2
2016
28
0.250
 Why?
Heart
3
2018
637
0.240
 Why?
Lymph Node Excision
2
2019
164
0.240
 Why?
Risk Assessment
6
2023
3240
0.240
 Why?
Child, Preschool
5
2024
10518
0.240
 Why?
Antimetabolites, Antineoplastic
2
2017
91
0.230
 Why?
Magnetic Resonance Imaging
4
2019
3408
0.230
 Why?
Leukemia
2
2017
230
0.230
 Why?
Transplantation, Haploidentical
1
2024
21
0.230
 Why?
Central Nervous System
3
2021
257
0.220
 Why?
Mediastinum
3
2019
24
0.220
 Why?
Risk Factors
5
2021
9763
0.220
 Why?
Lymphatic Metastasis
3
2014
320
0.210
 Why?
Lymphadenopathy
1
2023
9
0.210
 Why?
Antineoplastic Agents
5
2024
2061
0.210
 Why?
Cord Blood Stem Cell Transplantation
1
2024
99
0.210
 Why?
Transplantation Conditioning
1
2024
166
0.210
 Why?
Neoplasm Grading
4
2019
285
0.200
 Why?
Remission Induction
3
2018
272
0.200
 Why?
Postoperative Complications
1
2014
2483
0.200
 Why?
Protons
2
2020
80
0.200
 Why?
Cohort Studies
6
2024
5420
0.190
 Why?
Bone Neoplasms
1
2024
231
0.190
 Why?
Brain Stem Neoplasms
1
2023
89
0.190
 Why?
Radiometry
2
2019
47
0.190
 Why?
Chemotherapy, Adjuvant
2
2013
381
0.190
 Why?
Gastric Mucosa
2
2019
52
0.190
 Why?
Transplantation, Autologous
3
2018
211
0.190
 Why?
Survivors
2
2023
464
0.190
 Why?
Mitogen-Activated Protein Kinase 7
1
2021
21
0.190
 Why?
Multimodal Imaging
3
2017
110
0.190
 Why?
Poly(ADP-ribose) Polymerases
1
2021
94
0.180
 Why?
Radium
1
2020
3
0.180
 Why?
Breath Holding
2
2017
7
0.180
 Why?
Long Term Adverse Effects
1
2020
12
0.180
 Why?
Cranial Irradiation
2
2023
68
0.170
 Why?
Lung Neoplasms
2
2024
2344
0.170
 Why?
Cardiology
1
2022
261
0.160
 Why?
Stem Cell Transplantation
2
2018
166
0.160
 Why?
Clinical Trials as Topic
1
2024
1004
0.160
 Why?
Postoperative Care
2
2019
240
0.160
 Why?
Skin Neoplasms
2
2018
825
0.160
 Why?
Plasmacytoma
1
2019
16
0.160
 Why?
Radiation Dosage
1
2020
153
0.160
 Why?
CD4-CD8 Ratio
1
2018
22
0.160
 Why?
Glioma
1
2023
354
0.150
 Why?
Mycosis Fungoides
1
2018
61
0.150
 Why?
Methotrexate
2
2017
249
0.150
 Why?
Electrons
1
2018
79
0.150
 Why?
Area Under Curve
1
2019
304
0.150
 Why?
Breast Neoplasms, Male
1
2018
29
0.150
 Why?
Peritoneal Neoplasms
1
2019
87
0.150
 Why?
Radiotherapy Setup Errors
1
2017
3
0.140
 Why?
Platelet Count
1
2017
82
0.140
 Why?
Autografts
1
2018
42
0.140
 Why?
Hypothyroidism
1
2018
70
0.140
 Why?
Craniospinal Irradiation
1
2017
5
0.140
 Why?
Dendritic Cell Sarcoma, Follicular
1
2017
2
0.140
 Why?
Eye Neoplasms
1
2017
16
0.140
 Why?
Vincristine
4
2019
109
0.140
 Why?
Uncertainty
1
2017
116
0.140
 Why?
Leukocyte Count
1
2017
326
0.140
 Why?
Osteogenesis Imperfecta
2
2007
13
0.130
 Why?
Spinal Cord Diseases
1
2017
41
0.130
 Why?
Pentostatin
1
2016
1
0.130
 Why?
Neoplasm, Residual
1
2017
120
0.130
 Why?
Axilla
2
2017
45
0.130
 Why?
Photopheresis
1
2016
9
0.130
 Why?
Predictive Value of Tests
3
2022
1952
0.130
 Why?
Methylprednisolone
1
2016
83
0.130
 Why?
Collagen Type I
2
2007
119
0.130
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
99
0.130
 Why?
Plasmablastic Lymphoma
1
2015
7
0.130
 Why?
Confidence Intervals
1
2016
317
0.130
 Why?
Antibiotics, Antineoplastic
1
2016
123
0.130
 Why?
Anxiety
1
2023
965
0.120
 Why?
Congenital Abnormalities
1
2016
74
0.120
 Why?
Abortion, Spontaneous
1
2016
100
0.120
 Why?
Drug Resistance, Neoplasm
2
2019
759
0.120
 Why?
Fatal Outcome
1
2016
300
0.120
 Why?
Hysterectomy
2
2013
118
0.120
 Why?
Proportional Hazards Models
4
2020
1201
0.120
 Why?
Transplantation, Homologous
1
2016
401
0.120
 Why?
Tacrolimus
1
2016
193
0.120
 Why?
Coronary Artery Disease
1
2021
679
0.120
 Why?
Blood Platelets
1
2017
380
0.110
 Why?
Biomarkers
4
2021
3973
0.110
 Why?
Risk
1
2016
854
0.110
 Why?
Age Factors
1
2021
3144
0.110
 Why?
Etoposide
3
2018
148
0.110
 Why?
Receptors, Progesterone
2
2014
343
0.110
 Why?
Kidney Neoplasms
1
2018
350
0.110
 Why?
Cyclophosphamide
3
2019
232
0.110
 Why?
Receptor, ErbB-2
2
2014
326
0.110
 Why?
Rituximab
3
2019
164
0.100
 Why?
Caregivers
1
2020
815
0.100
 Why?
Spinal Cord
1
2015
356
0.100
 Why?
Carboplatin
1
2013
140
0.100
 Why?
Receptors, Estrogen
2
2014
426
0.100
 Why?
Lung
2
2016
3931
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2021
1052
0.100
 Why?
Anti-Inflammatory Agents
1
2016
480
0.100
 Why?
Pelvis
1
2013
104
0.100
 Why?
Fluorouracil
1
2013
199
0.100
 Why?
Radiotherapy, Conformal
1
2012
70
0.100
 Why?
Paclitaxel
1
2013
217
0.100
 Why?
Neutrophils
1
2017
1205
0.100
 Why?
Health Knowledge, Attitudes, Practice
1
2020
1279
0.100
 Why?
Immunoenzyme Techniques
1
2012
213
0.090
 Why?
Immunohistochemistry
1
2016
1698
0.090
 Why?
Immunosuppressive Agents
1
2016
853
0.090
 Why?
Cisplatin
1
2013
300
0.090
 Why?
Brain
2
2020
2679
0.090
 Why?
Immunotherapy
1
2015
592
0.090
 Why?
Triple Negative Breast Neoplasms
1
2014
197
0.090
 Why?
Models, Biological
1
2018
1722
0.090
 Why?
Contrast Media
1
2013
393
0.090
 Why?
Liver Neoplasms
1
2014
640
0.080
 Why?
Prospective Studies
3
2021
7131
0.080
 Why?
Patient Compliance
1
2013
565
0.080
 Why?
Polymorphism, Single Nucleotide
1
2016
2073
0.080
 Why?
Dose-Response Relationship, Radiation
2
2020
132
0.080
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2019
87
0.070
 Why?
United States
2
2021
13900
0.070
 Why?
Biomarkers, Tumor
1
2014
1181
0.070
 Why?
Prednisone
2
2019
233
0.070
 Why?
Colorectal Neoplasms
1
2014
752
0.070
 Why?
Cytarabine
2
2018
57
0.070
 Why?
Practice Guidelines as Topic
1
2014
1501
0.070
 Why?
Time Factors
4
2018
6556
0.070
 Why?
Proteoglycans
1
2007
110
0.070
 Why?
Integrins
1
2007
94
0.070
 Why?
Treatment Failure
2
2018
340
0.060
 Why?
Glycine
1
2006
165
0.060
 Why?
Amino Acid Substitution
1
2006
282
0.060
 Why?
Clinical Decision-Making
2
2019
302
0.060
 Why?
Neoplasm Invasiveness
2
2017
485
0.060
 Why?
X-ray Repair Cross Complementing Protein 1
1
2023
14
0.050
 Why?
Intelligence Tests
1
2023
58
0.050
 Why?
Standard of Care
1
2024
72
0.050
 Why?
X-Rays
1
2023
27
0.050
 Why?
Cell- and Tissue-Based Therapy
1
2024
75
0.050
 Why?
Regression Analysis
2
2016
993
0.050
 Why?
Proto-Oncogene Proteins c-sis
1
2023
35
0.050
 Why?
Terminology as Topic
1
2024
204
0.050
 Why?
Inducible T-Cell Co-Stimulator Protein
1
2022
9
0.050
 Why?
Analysis of Variance
2
2016
1288
0.050
 Why?
Cytidine Deaminase
1
2023
57
0.050
 Why?
Phenotype
3
2021
3076
0.050
 Why?
Brain Stem
1
2023
98
0.050
 Why?
Ribose
1
2021
22
0.050
 Why?
Radiosurgery
1
2024
321
0.050
 Why?
Adenosine Diphosphate
1
2021
80
0.050
 Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
42
0.050
 Why?
Troponin T
1
2021
57
0.050
 Why?
Feedback
1
2021
162
0.040
 Why?
Immunotherapy, Adoptive
1
2024
295
0.040
 Why?
Automation
1
2020
82
0.040
 Why?
Neoplasms, Radiation-Induced
1
2020
71
0.040
 Why?
Prevalence
2
2016
2564
0.040
 Why?
Risk Management
1
2020
85
0.040
 Why?
Incidence
2
2016
2644
0.040
 Why?
Neoplasms, Second Primary
1
2020
106
0.040
 Why?
Workflow
1
2020
155
0.040
 Why?
Neuropsychological Tests
1
2023
1015
0.040
 Why?
Mesentery
1
2019
47
0.040
 Why?
Safety
1
2020
331
0.040
 Why?
Busulfan
1
2018
15
0.040
 Why?
Melphalan
1
2018
29
0.040
 Why?
Respiration
1
2019
191
0.040
 Why?
Carmustine
1
2018
50
0.040
 Why?
Inhalation
1
2017
28
0.040
 Why?
Cone-Beam Computed Tomography
1
2017
30
0.040
 Why?
Subacute Combined Degeneration
1
2017
1
0.030
 Why?
Breast
1
2018
153
0.030
 Why?
Time-to-Treatment
1
2019
180
0.030
 Why?
Photons
1
2017
64
0.030
 Why?
Organ Sparing Treatments
1
2017
32
0.030
 Why?
Phosphorylation
1
2021
1713
0.030
 Why?
Deoxycytidine
1
2018
165
0.030
 Why?
Orbit
1
2017
57
0.030
 Why?
Injections, Spinal
1
2017
109
0.030
 Why?
Lymph Nodes
1
2019
472
0.030
 Why?
New York
1
2016
128
0.030
 Why?
Homocysteine
1
2017
152
0.030
 Why?
Procarbazine
1
2015
8
0.030
 Why?
Transforming Growth Factor beta1
1
2016
157
0.030
 Why?
Observer Variation
1
2016
315
0.030
 Why?
Mutation
1
2007
3717
0.030
 Why?
Genetic Markers
1
2016
338
0.030
 Why?
Animals
2
2021
35360
0.030
 Why?
Folic Acid
1
2017
184
0.030
 Why?
Texas
1
2016
228
0.030
 Why?
Mitochondria
1
2021
877
0.030
 Why?
Secondary Prevention
1
2016
218
0.030
 Why?
Molecular Targeted Therapy
1
2018
390
0.030
 Why?
Gastrointestinal Diseases
1
2016
198
0.030
 Why?
Pregnancy Outcome
1
2017
390
0.030
 Why?
Diagnostic Imaging
1
2017
334
0.030
 Why?
Abortion, Induced
1
2016
101
0.030
 Why?
Pregnancy
2
2017
6402
0.030
 Why?
Drug Administration Schedule
1
2016
769
0.030
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
278
0.030
 Why?
Acute Disease
1
2016
980
0.030
 Why?
Postpartum Period
1
2016
332
0.030
 Why?
Mastectomy
1
2014
131
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2018
857
0.030
 Why?
Ultrasonography
1
2016
716
0.020
 Why?
Multivariate Analysis
1
2016
1502
0.020
 Why?
Diagnosis, Differential
1
2017
1434
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2018
1056
0.020
 Why?
Medical Oncology
1
2014
272
0.020
 Why?
Ovariectomy
1
2012
137
0.020
 Why?
Comorbidity
1
2016
1547
0.020
 Why?
Severity of Illness Index
1
2019
2742
0.020
 Why?
Quality of Life
1
2021
2704
0.020
 Why?
Electronic Health Records
1
2017
975
0.020
 Why?
Kidney
1
2017
1385
0.020
 Why?
Diet
1
2017
1213
0.020
 Why?
Reproducibility of Results
1
2016
3083
0.020
 Why?
Anti-Bacterial Agents
1
2019
1717
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2282
0.020
 Why?
Infant
1
2020
9025
0.020
 Why?
Electrophoresis
1
2006
30
0.020
 Why?
Case-Control Studies
1
2014
3381
0.020
 Why?
DNA Mutational Analysis
1
2007
387
0.020
 Why?
Databases, Genetic
1
2007
232
0.020
 Why?
Collagen
1
2007
434
0.010
 Why?
Protein Structure, Tertiary
1
2007
840
0.010
 Why?
Mice
1
2021
16937
0.010
 Why?
Binding Sites
1
2007
1252
0.010
 Why?
Protein Binding
1
2007
2121
0.010
 Why?
Cells, Cultured
1
2006
4083
0.010
 Why?
Milgrom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (347) concept(s)
_
Co-Authors Expand Description
See all (37) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)